Did I read that correctly from their site? phase 2 will be concluded this month?
"ICX-TRC clinical and commercial development
Phase I clinical trials (safety) have been completed in seven volunteers at a single UK transplant centre. No safety issues have arisen and five out of seven patients have shown increased hair numbers.
The treatment phase of a Phase II trial, being conducted by Dr Bessam Farjo in Manchester, to optimise the delivery of the DP cells, has been completed.
In this trial, hair counts were obtained by shaving and photographing a small section of scalp, injecting it and then applying a specialised image analysis system to provide a total hair count. Two sub-groups were each injected with autologous DP cells using different delivery techniques. The scalps of one of the sub-groups were stimulated at the time of delivery.
At 24 weeks the results were as follows:
· Of the sub-group of five subjects without stimulation of the scalp, three or 60% showed an increase in hair count
· Of the sub-group of nine subjects with scalp stimulation, eight or 89% showed an increase in hair count.
These data are consistent with the earlier data reported in September 2007 and the hypothesis that new hair production is improved by pre-stimulation of the scalp, leading to an interaction between the injected cells and the resident hair producing cells. At the end of the first quarter of 2009, when the trial has concluded, photographic data will be analysed from a much larger area of treated scalp on all subjects at 12 months. Currently, three subjects have been lost to follow up.
Intercytex is exploring partnering opportunities to continue the next clinical phase of development of ICX-TRC."